Literature DB >> 29211669

Use of Liver Imaging and Biopsy in Clinical Practice.

Elliot B Tapper1,2, Anna S-F Lok1.   

Abstract

Mesh：

Year:  2017        PMID： 29211669     DOI： 10.1056/NEJMc1712445

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  Frequency of technical success of two-dimensional ultrasound shear wave elastography in a large pediatric and young adult cohort: a clinical effectiveness study.

Authors:  Nathan A Northern; Jonathan R Dillman; Andrew T Trout
Journal:  Pediatr Radiol       Date:  2019-04-04

Review 2.  AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review.

Authors:  Rohit Loomba; Joseph K Lim; Heather Patton; Hashem B El-Serag
Journal:  Gastroenterology       Date:  2020-01-30       Impact factor: 22.682

3.  Screening for Nonalcoholic Fatty Liver Disease in the Primary Care Clinic.

Authors:  Vijay Pandyarajan; Robert G Gish; Naim Alkhouri; Mazen Noureddin
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-07

4.  Annual Meeting of the Canadian Association for the Study of the Liver (CASL), the Canadian Network on Hepatitis C (CANHEPC) and the Canadian Association of Hepatology Nurses (CAHN) 2021 Abstracts.

Authors: 
Journal:  Can Liver J       Date:  2021-04-29

5.  Liver Fibrosis is Associated with Ischemic Stroke Risk in Women but not Men: The REGARDS Study.

Authors:  Neal S Parikh; Insu Koh; Lisa B VanWagner; Mitchell S V Elkind; Neil A Zakai; Mary Cushman
Journal:  J Stroke Cerebrovasc Dis       Date:  2021-04-16       Impact factor: 2.677

6.  Albumin-bilirubin score indicates liver fibrosis staging and prognosis in patients with chronic hepatitis C.

Authors:  Koji Fujita; Kyoko Oura; Hirohito Yoneyama; Tingting Shi; Kei Takuma; Mai Nakahara; Tomoko Tadokoro; Takako Nomura; Asahiro Morishita; Kunihiko Tsutsui; Takashi Himoto; Tsutomu Masaki
Journal:  Hepatol Res       Date:  2019-05-17       Impact factor: 4.288

7.  MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis.

Authors:  Jinho Jung; Rohan R Loomba; Kento Imajo; Egbert Madamba; Sanil Gandhi; Ricki Bettencourt; Seema Singh; Carolyn Hernandez; Mark A Valasek; Cynthia Behling; Lisa Richards; Katie Fowler; Claude B Sirlin; Atsushi Nakajima; Rohit Loomba
Journal:  Gut       Date:  2020-11-19       Impact factor: 23.059

8.  Exploring the Protective Effects and Mechanism of Crocetin From Saffron Against NAFLD by Network Pharmacology and Experimental Validation.

Authors:  Zijin Xu; Susu Lin; Junjie Gong; Peishi Feng; Yifeng Cao; Qiaoqiao Li; Yuli Jiang; Ya You; Yingpeng Tong; Ping Wang
Journal:  Front Med (Lausanne)       Date:  2021-06-09

9.  Albumin platelet product as a novel score for liver fibrosis stage and prognosis.

Authors:  Koji Fujita; Kazumi Yamasaki; Asahiro Morishita; Tingting Shi; Joji Tani; Noriko Nishiyama; Hideki Kobara; Takashi Himoto; Hiroshi Yatsuhashi; Tsutomu Masaki
Journal:  Sci Rep       Date:  2021-03-05       Impact factor: 4.379

10.  Mild Iron Overload as Seen in Individuals Homozygous for the Alpha-1 Antitrypsin Pi*Z Variant Does Not Promote Liver Fibrogenesis in HFE Knockout Mice.

Authors:  Nurdan Guldiken; Karim Hamesch; Shari Malan Schuller; Mahmoud Aly; Cecilia Lindhauer; Carolin V Schneider; Malin Fromme; Christian Trautwein; Pavel Strnad
Journal:  Cells       Date:  2019-11-09       Impact factor: 6.600
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.